BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23149615)

  • 21. Evaluation of treatment response and tissue necrosis as prognostic indicators following neoadjuvant chemoradiotherapy in rectal cancer patients.
    Jung JH; An HJ; Kim HJ; Lee J; Lee KM; Kim SH; Cho HM; Shim BY
    Korean J Intern Med; 2016 Jan; 31(1):134-44. PubMed ID: 26767867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case report of locally recurrent rectal cancer after low anterior resection that led to a pathological complete response to neoadjuvant chemoradiotherapy].
    Matsushita A; Takemoto H; Ikeda M; Munakata T; Fukunaga M; Kawabata R; Yamamoto T; Oda K; Kishimoto T; Imamura H; Ohzato H
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2261-3. PubMed ID: 23268043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pronounced tumour regression after radiotherapy is associated with negative/weak glucose transporter-1 expression in rectal cancer.
    Korkeila E; Jaakkola PM; Syrjänen K; Pyrhönen S; Sundström J
    Anticancer Res; 2011 Jan; 31(1):311-5. PubMed ID: 21273616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Portal pneumatosis as a complication of neoadjuvant chemoradiotherapy for rectal cancer: a case report.
    Arredondo J; Pastor C; Amoza S; Oronoz B; Arbea L; Hernández-Lizoain JL
    Colorectal Dis; 2011 Nov; 13(11):e383-4. PubMed ID: 21689357
    [No Abstract]   [Full Text] [Related]  

  • 25. High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
    Lin CY; Hsieh PL; Chou CL; Yang CC; Lee SW; Tian YF; Shiue YL; Li WS
    Oncology; 2020; 98(8):549-557. PubMed ID: 32408308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAGNETIC RESONANCE IMAGING TO EVALUATE NEOADJUVANT THERAPY EFFECTS ON RECTAL CARCINOMA.
    Sofić A; Vukobrat-Bijedić Z; Husić-Selimović A; Šehović N; Buija D; Eminagić D; Banjin M; Đuran A
    Acta Clin Croat; 2015 Sep; 54(3):303-8. PubMed ID: 26666099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
    Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
    Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    Shen J; Zhu Y; Wu W; Zhang L; Ju H; Fan Y; Zhu Y; Luo J; Liu P; Zhou N; Lu K; Zhang N; Li D; Liu L
    Med Sci Monit; 2017 Jan; 23():315-324. PubMed ID: 28100902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Jäger T; Neureiter D; Fallaha M; Schredl P; Kiesslich T; Urbas R; Klieser E; Holzinger J; Sedlmayer F; Emmanuel K; Dinnewitzer A
    Strahlenther Onkol; 2018 Nov; 194(11):991-1006. PubMed ID: 30069738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Choice of neoadjuvant therapy for rectal cancer: simple chemotherapy or synchronous chemoradiotherapy].
    Li J; Deng Y; Wang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):627-631. PubMed ID: 29968236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Lim SH; Chua W; Henderson C; Ng W; Shin JS; Chantrill L; Asghari R; Lee CS; Spring KJ; de Souza P
    Crit Rev Oncol Hematol; 2015 Oct; 96(1):67-80. PubMed ID: 26032919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
    Petrucciani N; Carra MC; Martínez-Pérez A; Vitali GC; Landi F; Genova P; Memeo R; Brunetti F; Espin E; Ris F; De'angelis N;
    Anticancer Res; 2019 Apr; 39(4):2113-2120. PubMed ID: 30952757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation.
    García-Albéniz X; Gallego R; Hofheinz RD; Fernández-Esparrach G; Ayuso-Colella JR; Bombí JA; Conill C; Cuatrecasas M; Delgado S; Ginés A; Miquel R; Pagés M; Pineda E; Pereira V; Sosa A; Reig O; Victoria I; Feliz L; María de Lacy A; Castells A; Burkholder I; Hochhaus A; Maurel J
    World J Gastroenterol; 2014 Nov; 20(42):15820-9. PubMed ID: 25400468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total neoadjuvant therapy for rectal cancer.
    Goodman KA
    Cancer Radiother; 2018 Sep; 22(5):459-465. PubMed ID: 29807808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neoadjuvant chemoradiotherapy for locally advanced rectal cancer].
    Kuriu Y; Kokuba Y; Murayama Y; Komatsu S; Shiozaki A; Ikoma H; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Otsuji E
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1951-3. PubMed ID: 23267940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research progress on pathologic complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer].
    Peng HH; You KY; Gao YH; Wen BX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):592-6. PubMed ID: 23801217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy.
    Runau F; Collins A; Fenech GA; Ford E; Dimitriou N; Chaudhri S; Yeung JM
    Int J Colorectal Dis; 2017 Mar; 32(3):341-348. PubMed ID: 27885480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer.
    Miller ED; Robb BW; Cummings OW; Johnstone PA
    Dis Colon Rectum; 2012 Sep; 55(9):1002-7. PubMed ID: 22874609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.